United States Ultrasound Devices Market Poised for a Smarter, Portable, and AI-Driven Era (2025–2033)

The heartbeat of American healthcare is evolving quickly—and one of the clearest signals of this transformation is the accelerating demand for ultrasound devices. Once confined to radiology wings and maternity rooms, ultrasound technology has now become mobile, intelligent, and indispensable across nearly every medical specialty.

According to Renub Research, the United States Ultrasound Devices Market is projected to reach US$ 4.36 billion by 2033, up from US$ 2.75 billion in 2024, expanding at a compound annual growth rate (CAGR) of 5.27% from 2025 to 2033. This upward curve reflects a sweeping shift in healthcare delivery—driven by an aging population, explosion of chronic diseases, demand for non-invasive diagnostics, and the rapid convergence of portability and artificial intelligence (AI) in imaging technologies.

Yet these numbers, while impressive, only tell part of the story. To understand this industry’s true momentum, we must look deeper into the forces shaping it, the opportunities opening up, and the technological reinvention happening in real time within hospitals, clinics, and even at the patient bedside.

Ultrasound Is No Longer an Option—It’s a Necessity

Ultrasound imaging has become a cornerstone of modern diagnostics because it meets the most urgent needs of 21st-century healthcare:

✅ Non-invasive, painless, and radiation-free

✅ Real-time imaging for rapid clinical decisions

✅ Applicable across cardiology, oncology, gynecology, emergency care, orthopedics, vascular medicine, and more

✅ Increasingly portable and cost-efficient

Where CT and MRI scans remain critical for highly complex conditions, ultrasound fills the broader and faster gap—allowing clinicians to scan first, diagnose early, and treat faster.

And as more healthcare moves beyond traditional hospital walls, ultrasound is rapidly becoming the device of choice at the point of care.

Market Snapshot (2024–2033)

Report Feature Details

Base Year 2024

Forecast Period 2025–2033

Market Value (2024) US$ 2.75 Billion

Projected Value (2033) US$ 4.36 Billion

CAGR (2025–2033) 5.27%

What’s Fuelling This Growth?

1. The Rise of Pocket-Sized Ultrasound Machines

Healthcare is leaving the desk and entering the pocket. The rapid adoption of handheld and compact ultrasound systems has reshaped decision-making in emergency rooms, ICUs, orthopedic clinics, and even home health settings.

A landmark example: In September 2022, Koninklijke Philips N.V. received FDA approval for its 5000-series compact ultrasound system for cardiology, OB-GYN, general imaging, and point-of-care diagnostics—demonstrating the rising trust and regulatory support for mobile ultrasound.

Compact systems are winning not just because they’re small, but because they’re:

Faster to deploy

Cheaper to maintain

Ideal for remote care delivery

Easy for clinicians to adopt with minimal training

2. Chronic Disease Rates Are Surging—So Is the Need for Frequent Imaging

The United States continues to grapple with rising cases of:

Cardiovascular disease

Breast, liver, and other cancers

Neurological disorders

Musculoskeletal conditions

These illnesses require recurring evaluation, ongoing monitoring, and early detection, all of which ultrasound can provide at a lower cost and lower risk than radiation-based imaging.

Unlike CT or MRI, ultrasound enables rapid repeat scans—making it perfect for follow-ups, prenatal checkups, oncology monitoring, and real-time intervention guidance.

3. Government Support for Early Diagnostics

Policies like the Affordable Care Act (ACA) have expanded healthcare access, indirectly increasing demand for diagnostic imaging. In parallel, federal and state initiatives encouraging early disease detection, cancer screening, maternal health, and preventive care continue to legitimize ultrasound as a front-line medical tool.

4. Technology Is Making Ultrasound Smarter

We are no longer talking about simple grayscale scans. Today’s ultrasound ecosystem includes:

3D/4D imaging

AI-driven interpretation

Automated lesion detection

Needle navigation and guidance

Cloud-connected diagnostics

Case in point: In July 2023, FUJIFILM Sonosite launched Sonosite ST, featuring:

21-inch all-touch display

Auto Steep Needle Profiling (SNP)

Automatic image optimization

These advancements are shrinking diagnostic timelines while improving accuracy.

Headwinds the Market Must Navigate

⚠ Competition From High-Resolution Imaging

MRI and CT scans continue to dominate areas requiring ultra-detailed imaging—such as complex brain disorders, tumor staging, and advanced cardiac assessments. While ultrasound wins on speed and safety, it still faces limitations in depth and structural detail in specialized cases.

⚠ High Upgrade & Integration Barriers

Integrating AI-capable ultrasound systems is expensive. Hospitals must upgrade hardware, deploy new software, restructure data architecture, and retrain clinicians—a heavy lift, especially for smaller facilities with tight budgets.

Therapeutic Ultrasound: The Quiet but Powerful Growth Story

Beyond diagnostics, therapeutic ultrasound is emerging as a high-value segment, especially in:

Pain management

Sports injury rehabilitation

Physiotherapy

Musculoskeletal treatments

As the U.S. population ages and remains physically active longer, demand for non-surgical, non-invasive therapies continues to accelerate.

Who’s Using Ultrasound the Most?

Device Type Dominance

📌 Trolley/Cart-based Ultrasound Systems still command the largest market share, because they support:

Advanced imaging modes

Higher processing power

Multi-department deployment

3D/4D and Doppler capabilities

Top Application Segment

📌 Radiology & General Imaging remains the largest user base due to its broad clinical usage across abdominal, vascular, musculoskeletal, and diagnostic scanning.

Primary End-User

📌 Hospitals lead the market, thanks to their multidisciplinary infrastructure, higher patient volume, emergency imaging needs, and ability to deploy both premium and handheld systems.

Market Segmentation

By Product

Diagnostics Ultrasound

Therapeutic Ultrasound

By Portability

Trolley/Cart-based Devices

Compact/Handheld Devices

By Application

Radiology/General Imaging

Cardiology

Gynecology

Vascular

Urology

Others

By End-User

Hospitals

Surgical Centers

Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Academic Institutions

Competitive Landscape

The U.S. ultrasound market is led by companies investing heavily in AI, mobility, precision imaging, and clinical accessibility.

Top Companies Covered:

GE Healthcare

Healthcare Hologic Inc.

Butterfly Network

Hitachi Healthcare Americas

Samsung Electronics Co., Ltd

Hologic, Inc.

Fujifilm Holdings Corporation

These players are competing through product innovation, acquisitions, ergonomic design, AI integration, and expanded clinical capabilities.

So, Where Is the Market Headed Next?

With patient care decentralizing, diagnostics shifting toward early detection, and AI making imaging smarter and more accurate, ultrasound is evolving into a first-line clinical decision tool rather than a secondary diagnostic option.

In the coming decade, the United States healthcare system will likely witness:

✔ More handheld ultrasound adoption across emergency and outpatient care

✔ Expansion of AI-powered image classification and clinical decision support

✔ Increased reimbursement support for point-of-care imaging

✔ Broader use of therapeutic ultrasound in rehabilitation and sports medicine

✔ Seamless integration with cloud data, telemedicine, and remote diagnostics

Final Thoughts

Ultrasound devices are no longer just imaging tools—they are the nervous system of modern diagnostics, enabling faster decisions, personalized treatments, and safer patient outcomes.

The forecast by Renub Research is not just a market projection—it is evidence of a healthcare revolution guided by smart devices, mobility, and preventative medicine.

As the industry pushes forward, one thing is certain: the future of ultrasound is no longer inside the machine—it’s in the hands of the clinician, at the bedside of the patient, and powered by AI.